913 related articles for article (PubMed ID: 16879890)
21. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
Baskin-Bey ES; Moreno Luna LE; Gores GJ
J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
[No Abstract] [Full Text] [Related]
22. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.
Azeem N; Gostout CJ; Knipschield M; Baron TH
Gastrointest Endosc; 2014 May; 79(5):773-779.e2. PubMed ID: 24206748
[TBL] [Abstract][Full Text] [Related]
23. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
[TBL] [Abstract][Full Text] [Related]
24. [Cytology is in pivotal role at screening and surveillance of PSC].
Boyd S; Arola J; Mäkisalo H; Färkkilä M
Duodecim; 2014; 130(22-23):2397-404. PubMed ID: 25558600
[TBL] [Abstract][Full Text] [Related]
25. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
26. Early detection and treatment of cholangiocarcinoma.
Gores GJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
[TBL] [Abstract][Full Text] [Related]
28. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moff SL; Clark DP; Maitra A; Pandey A; Thuluvath PJ
J Clin Gastroenterol; 2006 Apr; 40(4):336-41. PubMed ID: 16633106
[TBL] [Abstract][Full Text] [Related]
29. Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis.
Vannas MJ; Boyd S; Färkkilä MA; Arola J; Isoniemi H
Liver Int; 2017 May; 37(5):735-742. PubMed ID: 28453918
[TBL] [Abstract][Full Text] [Related]
30. Role of biliary brush cytology in primary sclerosing cholangitis.
Lal A; Okonkwo A; Schindler S; De Frias D; Nayar R
Acta Cytol; 2004; 48(1):9-12. PubMed ID: 14969174
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of biliary tract lesions by histological sectioning of brush bristles as alternative to cytological smearing.
Asioli S; Accinelli G; Pacchioni D; Bussolati G
Am J Gastroenterol; 2008 May; 103(5):1274-81. PubMed ID: 18177458
[TBL] [Abstract][Full Text] [Related]
32. Benign, dysplastic, or malignant--making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients.
Lee JG; Leung JW; Baillie J; Layfield LJ; Cotton PB
Am J Gastroenterol; 1995 May; 90(5):722-6. PubMed ID: 7733076
[TBL] [Abstract][Full Text] [Related]
33. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
34. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
35. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
37. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
Feldmann G; Nattermann J; Nischalke HD; Gorschlüter M; Kuntzen T; Ahlenstiel G; Gerhardt T; Wolff M; Sauerbruch T; Spengler U; Dumoulin FL
Endoscopy; 2006 Jun; 38(6):604-9. PubMed ID: 16673309
[TBL] [Abstract][Full Text] [Related]
38. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
[TBL] [Abstract][Full Text] [Related]
39. Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis ?
John AR; Haghighi KS; Taniere P; Esmat ME; Tan YM; Bramhall SR
Dig Surg; 2006; 23(5-6):319-24. PubMed ID: 17170527
[TBL] [Abstract][Full Text] [Related]
40. Biliary brushing cytology.
Selvaggi SM
Cytopathology; 2004 Apr; 15(2):74-9. PubMed ID: 15056166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]